TY - JOUR
T1 - Human papillomavirus and cervical cancer behavioral surveillance in the US
AU - Tiro, Jasmin A.
AU - Saraiya, Mona
AU - Jain, Nidhi
AU - Liddon, Nicole
AU - Cokkinides, Vilma
AU - Lai, Sue Min
AU - Breen, Nancy
AU - Wideroff, Louise
PY - 2008/11/15
Y1 - 2008/11/15
N2 - In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.
AB - In the US, federal and state behavioral surveillance systems routinely monitor self-reported sexual behavior and Papanicolaou (Pap) test use to identify high-risk populations, trends, and disparities and to guide and evaluate interventions for cervical cancer prevention and control. Clinical uptake of human papillomavirus (HPV) vaccination and testing necessitates the expansion of behavioral surveillance systems. Cervical disease is the main focus of HPV-related behavioral surveillance because of greater cancer incidence and mortality relative to other susceptible organs, and the availability of effective technologies for prevention and control. In the current study, a framework is presented for the types of behaviors to monitor, their conceptual and operational definitions, target populations, and evidence supporting the reliability and validity of self-report measures. An overview is also provided of 8 population-based and 2 provider-based data systems that are nationally representative and accessible for behavioral surveillance research. Ongoing surveillance at the national, state, and local level is critical for monitoring the dissemination of HPV technologies and their impact on reducing disparities in the detection of precursor lesions, incidence of invasive cancer, and mortality.
KW - Behavioral surveillance
KW - Cervical cancer
KW - Human papillomavirus
KW - Papanicolaou test use
UR - http://www.scopus.com/inward/record.url?scp=56449091027&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=56449091027&partnerID=8YFLogxK
U2 - 10.1002/cncr.23760
DO - 10.1002/cncr.23760
M3 - Review article
C2 - 18980284
AN - SCOPUS:56449091027
SN - 0008-543X
VL - 113
SP - 3013
EP - 3030
JO - Cancer
JF - Cancer
IS - 10 SUPPL.
ER -